No Data
No Data
Trending Industry Today: DINGDANG HEALTH Leads Gains In Digital Health Stocks
CICC Leasing: Maintaining a "Outperform" rating on ali health with a target price of 4.5 Hong Kong dollars.
CICC Leong released a research report stating that it maintains a 'outperform' rating on Ali Health (00241), with the revenue growth rate for the fiscal year 2025 reduced to about 10%, but the net margin for 2025 increased to 5.5%, with a target price of HK$4.5. The current trading price of the stock is approximately 20 times the PE ratio for the fiscal year 2026, while the three-year compound annual growth rate of earnings per share is 22%. The report mentions that Ali Health is shifting its recent strategy focus from prescription pharmaceuticals to non-pharmaceuticals and over-the-counter drugs, which will bring pressure to the sales growth of prescription pharmaceuticals but will increase profitability. The bank believes that the online penetration rate of prescription pharmaceuticals is highly profitable.
Shu Yuming (301017.SZ): Shareholder ali health holding more than 5% of the shares intends to reduce the company's shareholding by no more than 3%.
On September 25, Gelonhui announced that Ali Health Technology (China) Co., Ltd. (referred to as "Ali Health" below), a shareholder holding more than 5% of the company, holds 34,080,000 shares of the company (8.47% of the total share capital). Ali Health plans to reduce its shareholding in the company by a total of 12,070,642 shares, not exceeding 3% of the total share capital, through centralized bidding and/or block trading within 3 months after the date of this announcement (from October 24, 2024 to January 23, 2025) after 15 trading days.
ali health [00241] is now trading at 3.3 Hong Kong dollars, up 5.10%.
As of 11:29, Ali Health [00241] reported 3.3 Hong Kong dollars, compared to the closing price of 3.14 Hong Kong dollars, an increase of 0.16 Hong Kong dollars or 5.10%, with a turnover of 89.1889 million Hong Kong dollars. The highest price today is 3.3 Hong Kong dollars, and the lowest price is 3.15 Hong Kong dollars. Based on the closing price of yesterday, the 10-day average price is 3.16 Hong Kong dollars, the 50-day average price is 3.07 Hong Kong dollars, and the current P/E ratio is 67.92 times, with a 14-day relative strength index of 44.76.
ali health (00241) granted a total of 4.0477 million restricted share units.
Ali Health (00241) announced that on September 13, 2024, the company implemented the 2024 share incentive plan...
Market Chatter: Maeil Dairies to Supply Specialized Infant Formula to China via Alibaba Health
No Data
No Data